Clinical trial
Combination Vaccination Before HIV Treatment Interruption
NCT00212888 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00212888 |
|---|---|
| Title | Combination Vaccination Before HIV Treatment Interruption |
| Official title | A Pilot Study to Determine the Impact of Therapeutic HIV Vaccination Followed by a Scheduled Interruption of Antiretroviral Therapy on HIV-Specific Immune Function and Virologic Rebound in Patients With Prolonged Viral Suppression |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Ontario HIV Treatment Network CIHR Canadian HIV Trials Network |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | Remune and ALVAC |
| Enrollment | 52 |
| Start date | Apr 1, 2004 |
| Primary completion | Jul 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 17, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: